Safety and administration of treatment with botulinum neurotoxin for sialorrhoea in ALS patients: Review of the literature and a proposal for tailored treatment
作者： Morten Gersel Stokholm , Carsten Bisgård , Ole Jakob Vilholm
DOI: 10.3109/21678421.2013.830312
关键词: Feeding tube 、 Amyotrophic lateral sclerosis 、 Botulinum neurotoxin 、 Physical therapy 、 MEDLINE 、 Tailored treatment 、 Intensive care medicine 、 Drooling 、 Medicine 、 Personalized treatment 、 Adverse effect
摘要: Botulinum neurotoxin (BoNT) is a second-line treatment of sialorrhoea in ALS (amyotrophic lateral sclerosis) patients. This article review the published literature concerning safety and administration this to A PubMed search was performed. All original publications on BoNT patients were included review. Only few adverse events observed with BoNT. The studies performed date have applied different strategies dosages. In conclusion, for safe effects. authors advocate implementation personalized strategy. Special precautions must be taken when do not assistance ventilator feeding tube.
informahealthcare.com
core.ac.uk 参考文章(36)
C. Lorenzano, S. Bagnato, F. Gilio, G. Fabbrini, A. Berardelli, No clinical or neurophysiological evidence of botulinum toxin diffusion to non-injected muscles in patients with hemifacial spasm. Neurotoxicity Research. ,vol. 9, pp. 141- 144 ,(2006) , 10.1007/BF03033932
Dana L. Suskind, Ann Tilton, Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy. Laryngoscope. ,vol. 112, pp. 73- 81 ,(2002) , 10.1097/00005537-200201000-00014
Okan Dogu, Demir Apaydin, Serhan Sevim, Derya Umit Talas, Mihriban Aral, Ultrasound-guided versus 'blind' intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson's disease. Clinical Neurology and Neurosurgery. ,vol. 106, pp. 93- 96 ,(2004) , 10.1016/J.CLINEURO.2003.10.012
M. Lim, A. Mace, S.A. Reza Nouraei, G. Sandhu, Botulinum toxin in the management of sialorrhoea: a systematic review. Clinical Otolaryngology. ,vol. 31, pp. 267- 272 ,(2006) , 10.1111/J.1749-4486.2006.01263.X
Eigild Møller, Merete Karlsborg, Allan Bardow, Joan Lykkeaa, Flemming H. Nissen, Merete Bakke, Treatment of severe drooling with botulinum toxin in amyotrophic lateral sclerosis and Parkinson's disease: efficacy and possible mechanisms. Acta Odontologica Scandinavica. ,vol. 69, pp. 151- 157 ,(2011) , 10.3109/00016357.2010.545035
Carlayne E. Jackson, Gary Gronseth, Jeffrey Rosenfeld, Richard J. Barohn, Richard Dubinsky, C. Blake Simpson, April McVey, Pamela P. Kittrell, Ruth King, Laura Herbelin, , Randomized double-blind study of botulinum toxin type B for sialorrhea in ALS patients. Muscle & Nerve. ,vol. 39, pp. 137- 143 ,(2009) , 10.1002/MUS.21213
Dayse Manrique, Aplicação de toxina botulínica tipo A para reduzir a saliva em pacientes com esclerose lateral amiotrófica Revista Brasileira De Otorrinolaringologia. ,vol. 71, pp. 566- 569 ,(2005) , 10.1590/S0034-72992005000500004
A. Lipp, T. Trottenberg, T. Schink, A. Kupsch, G. Arnold, A randomized trial of botulinum toxin A for treatment of drooling. Neurology. ,vol. 61, pp. 1279- 1281 ,(2003) , 10.1212/WNL.61.9.1279
G. Logroscino, B. J Traynor, O. Hardiman, A. Chio, D. Mitchell, R. J Swingler, A. Millul, E. Benn, E. Beghi, , Incidence of amyotrophic lateral sclerosis in Europe Journal of Neurology, Neurosurgery, and Psychiatry. ,vol. 81, pp. 385- 390 ,(2010) , 10.1136/JNNP.2009.183525
J. Costa, M. L. Rocha, J. Ferreira, T. Evangelista, M. Coelho, M. de Carvalho, Botulinum toxin type-B improves sialorrhea and quality of life in bulbaronset amyotrophic lateral sclerosis. Journal of Neurology. ,vol. 255, pp. 545- 550 ,(2008) , 10.1007/S00415-008-0738-5